Moreover, our measurements of AD-NAT, CRC-NAT, and N colonic biopsies showed significantly lower LINE-1 methylation in NAT samples vs. healthy controls, which also agreed with the recent scientific literature [8, 41, 42]. This evidence concerns the gene BRD2 and Alzheimer disease.